Bibliographic Details
| Title: |
The tetravalent, bispecific properties of FS118, an anti-LAG-3/PD-L1 antibody, mediate LAG-3 shedding from CD4 + and CD8 + tumor-infiltrating lymphocytes. |
| Authors: |
Reader CS; invoX Pharma., Liao W; F-star Therapeutics, Cambridge, UK., Potter-Landua BJ; invoX Pharma., Veyssier CS; invoX Pharma., Seal CJ; invoX Pharma., Brewis N; F-star Therapeutics, Cambridge, UK., Morrow M; invoX Pharma. |
| Source: |
Anti-cancer drugs [Anticancer Drugs] 2025 Jul 01; Vol. 36 (6), pp. 447-458. Date of Electronic Publication: 2025 Mar 03. |
| Publication Type: |
Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: |
Publisher: Lippincott Williams & Wilkins Country of Publication: England NLM ID: 9100823 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1473-5741 (Electronic) Linking ISSN: 09594973 NLM ISO Abbreviation: Anticancer Drugs Subsets: MEDLINE |
| Database: |
MEDLINE Ultimate |
